Must-know: Chilton Investment’s Company’s 4Q13 positions
Chilton Investment Company
Chilton Investment Company is run by Richard L. Chilton, Jr. The firm says on its website that it has evolved from managing one long-short equity strategy to managing numerous strategies across various sectors globally. Chilton’s $3.44 billion fourth quarter portfolio comprises 166 stocks. Chilton initiated positions in Abbott Laboratories (ABT), U.S. Bancorp (USB), Macy’s Inc. (M), and TransDigm Group Inc. (TDG). It sold its stakes in Genesco Inc. (GCO), Bally Technologies Inc. (BYI), and CarMax Inc. (KMX).
Interested in ABT? Don't miss the next report.
Receive e-mail alerts for new research on ABT
The firm describes itself as “a global investment management firm that aims to produce superior investment returns by aggressively seeking capital appreciation in rising markets and preserving capital in declining markets.” Chilton further states, “The firm takes a long-term perspective as it endeavors to maintain a focused, disciplined portfolio that consistently generates profits for its clients over time.”